Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 24311835)

1.

Synergistic antiosteoporotic effect of Lepidium sativum and alendronate in glucocorticoid-induced osteoporosis in Wistar rats.

Elshal MF, Almalki AL, Hussein HK, Khan JA.

Afr J Tradit Complement Altern Med. 2013 Aug 12;10(5):267-73. eCollection 2013.

2.

Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.

Xu D, Yang W, Zhou C, Liu Y, Xu B.

Planta Med. 2010 Nov;76(16):1809-13. doi: 10.1055/s-0030-1250040. Epub 2010 Jun 24.

PMID:
20577944
3.

Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate.

Bitto A, Burnett BP, Polito F, Levy RM, Marini H, Di Stefano V, Irrera N, Armbruster MA, Minutoli L, Altavilla D, Squadrito F.

Br J Pharmacol. 2009 Apr;156(8):1287-95. doi: 10.1111/j.1476-5381.2008.00100.x. Epub 2009 Mar 19.

4.

Antiosteoporotic activity of echinacoside in ovariectomized rats.

Li F, Yang X, Yang Y, Guo C, Zhang C, Yang Z, Li P.

Phytomedicine. 2013 Apr 15;20(6):549-57. doi: 10.1016/j.phymed.2013.01.001. Epub 2013 Feb 18.

PMID:
23428402
5.

Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.

Shomali T, Rezaian M, Rassouli A, Asadi F.

Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):46-50. doi: 10.1111/j.1742-7843.2009.00393.x. Epub 2009 Mar 19.

PMID:
19302435
6.

Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate.

Derakhshanian H, Djalali M, Djazayery A, Nourijelyani K, Ghadbeigi S, Pishva H, Saedisomeolia A, Bahremand A, Dehpour AR.

Can J Physiol Pharmacol. 2013 May;91(5):380-5. doi: 10.1139/cjpp-2012-0190. Epub 2013 Jan 22.

PMID:
23656499
7.

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.

Bone. 2010 Apr;46(4):935-9. doi: 10.1016/j.bone.2009.12.032. Epub 2010 Jan 6.

PMID:
20060081
8.

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.

Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K.

J Rheumatol. 2010 Jan;37(1):141-8. doi: 10.3899/jrheum.090411. Epub 2009 Nov 16.

PMID:
19918047
9.

Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.

Uchida K, Nakajima H, Miyazaki T, Yayama T, Kawahara H, Kobayashi S, Tsuchida T, Okazawa H, Fujibayashi Y, Baba H.

J Nucl Med. 2009 Nov;50(11):1808-14. doi: 10.2967/jnumed.109.062570. Epub 2009 Oct 16.

10.

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R.

N Engl J Med. 2007 Nov 15;357(20):2028-39.

11.

Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.

Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.

12.

Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.

El-Shitany NA, Hegazy S, El-Desoky K.

Phytomedicine. 2010 Feb;17(2):116-25. doi: 10.1016/j.phymed.2009.05.012. Epub 2009 Jul 3.

PMID:
19577454
13.

Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.

Khedr NF, El-Ashmawy NE, El-Bahrawy HA, Haggag AA, El-Abd EE.

Fundam Clin Pharmacol. 2013 Oct;27(5):526-34. doi: 10.1111/j.1472-8206.2012.01047.x. Epub 2012 Jul 4.

PMID:
22762129
14.

Effect of oviductus ranae and oviductus ranae eggs on bone metabolism and osteoporosis.

Wang DH, Wu W, Tian JM, Wang ZH, Wang DT, Xiang K, Zhu GY, Han T.

Chin J Integr Med. 2013 Jul;19(7):532-8. doi: 10.1007/s11655-012-1220-x. Epub 2012 Dec 21.

PMID:
23263999
15.

Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats.

Sung MJ, Davaatseren M, Hur HJ, Kim HJ, Ryu SY, Choi YH, Cha MR, Kwon DY.

Phytother Res. 2012 Aug;26(8):1182-8. doi: 10.1002/ptr.3714. Epub 2012 Jan 4.

PMID:
22821855
16.

Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life.

Panico A, Lupoli GA, Marciello F, Lupoli R, Cacciapuoti M, Martinelli A, Granieri L, Iacono D, Lupoli G.

Med Sci Monit. 2011 Aug;17(8):CR442-448.

17.

Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.

Jacobs JW, de Nijs RN, Lems WF, Geusens PP, Laan RF, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen AC, Bruyn GA, Dijkmans BA, Bijlsma JW.

J Rheumatol. 2007 May;34(5):1051-7. Epub 2007 Apr 1.

PMID:
17407214
19.

Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients.

Iwamoto J, Uzawa M, Sato Y, Takeda T, Matsumoto H.

J Bone Miner Metab. 2010 Mar;28(2):202-8. doi: 10.1007/s00774-009-0116-0. Epub 2009 Aug 19.

PMID:
19690798
20.

Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.

Bagi CM, Volberg M, Moalli M, Shen V, Olson E, Hanson N, Berryman E, Andresen CJ.

Anat Rec (Hoboken). 2007 Aug;290(8):1005-16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk